FindTrial
Sign In

The application value of FAPI in differentiated thyroid carcinoma

The value of fiber-activating protein (FAP) targeting probes in the diagnosis of low-risk differentiated thyroid cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089382
Enrollment
Unknown
Registered
2024-09-06
Start date
2024-05-09
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Interventions

observe group:none

Sponsors

Shanxi Bethune Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Thyroid cancer diagnosed by clinical or imaging examination; 2. Age =18 years old, male or female; 3. No other tumors or autoimmune diseases; 4. Patients intended to receive surgical treatment, and had not received any other related treatment before exam.

Exclusion criteria

Exclusion criteria: 1. The pregnant or lactating patients; 2. Patients with severe heart, lung, kidney and other organic diseases; 3. The patients combined with other tumors or autoimmune diseases, etc.

Design outcomes

Primary

MeasureTime frame
The SUVmax value ;—

Secondary

MeasureTime frame
the expression of FAP in pathology;—

Countries

China

Contacts

Public ContactYuhua Wang

Shanxi Bethune Hospital

xyl200197@163.com+86 134 0369 0935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026